Robert F. Kennedy Jr., tapped by President Donald Trump to lead the Health and Human Services Department, plans to continue collecting fees from a law firm suing a major pharmaceutical company, even if the Senate confirms him, The Hill reported.

Kennedy released his financial disclosure form Wednesday, revealing plans to maintain a fee arrangement with a law firm currently suing American pharmaceutical giant Merck.

According to the disclosure, Kennedy listed investments in companies such as Amazon, Dragonfly Therapeutics, and CRISPR Therapeutics, with values ranging from $1,001 to $50,000.

Read more at Newsmax© 2025 Newsmax. All rights reserved.